China's Zelixir Biotech predicts monkeypox protein structures for drug discovery
Drug Discovery | News | 0 Comment | 31 May, 2022
Zelixir Biotech, based in China, has predicted more than 600 structures and added functional annotations of proteins fro...Read more
Insilico Medicine explores use of 3CL protease inhibitor for COVID-19 treatment
Drug Discovery | News | 0 Comment | 25 May, 2022
Insilico Medicine, a China & US-based clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery c...Read more
Japanese firms initiate joint research on next-gen IT drug discovery technology
Drug Discovery | News | 0 Comment | 17 May, 2022
Japan-based Fujitsu and RIKEN have launched a joint research project on next-generation IT drug discovery technology uti...Read more
University of Tokyo, Astellas further advance development of innovative medicines
Drug Discovery | News | 0 Comment | 27 Apr, 2022
The University of Tokyo and Astellas Pharma Inc., in Japan, have entered the second phase of their collaboration for co-...Read more
FDA grants Fast Track designation for Paradigm Biopharmaceuticals Phase III Osteoarthritis Program
Drug Discovery | News | 0 Comment | 14 Apr, 2022
Australia's Paradigm Biopharmaceuticals, a clinical stage biopharmaceutical company focused on repurposing existing...Read more
TauRx's late-stage clinical trial reaches new milestone
Drug Discovery | News | 0 Comment | 14 Apr, 2022
TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer's Disease (AD) research, has announced that the last p...Read more
Otsuka and Akebia seek USFDA approval for renal anemia drug
Drug Discovery | News | 0 Comment | 01 Apr, 2022
Otsuka Pharmaceutical has announced that its collaborator Akebia Therapeutics, Inc. (Akebia) has submitted a New Drug Ap...Read more
Insilico Medicine partners with EQRx for AI-driven drug discovery
Drug Discovery | News | 0 Comment | 25 Mar, 2022
Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, has entered i...Read more
Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments
Drug Discovery | News | 0 Comment | 21 Mar, 2022
Biogen Inc. and Eisai Co., Ltd. announced that the companies have amended their existing collaboration agreement on aduc...Read more
RedHill inks deal worth $6M with Kukbo for COVID-19 drug in South Korea
Drug Discovery | News | 0 Comment | 16 Mar, 2022
RedHill Biopharma has entered into an exclusive license agreement with Kukbo Co., a South Korean corporation, for o...Read more
Astellas’ menopause drug fails in Asia trial
Drug Discovery | News | 0 Comment | 16 Mar, 2022
Japan-based Astellas Pharma Inc. has announced topline results from the ongoing Phase 3 MOONLIGHT 1 clinical trial inves...Read more
China approves SCG's T Cell Therapy IND to treat Hepatitis B virus
Drug Discovery | News | 0 Comment | 14 Mar, 2022
Singapore-based SCG Cell Therapy Pte Ltd, a leading biotechnology company, announced that the China National Medic...Read more
China's Gan & Lee Pharma begins first-in-human trial for diabetes drug
Drug Discovery | News | 0 Comment | 11 Mar, 2022
Chinese firm Gan & Lee Pharmaceuticals has announced that the first subject has been dosed in our Phase I, double-bl...Read more
Dr Andreas Amrein joins Advanced Clinical to lead global development and expansion in APAC
Drug Discovery | News | 0 Comment | 10 Mar, 2022
Advanced Clinical, a clinical development and strategic resourcing organization committed to providing a better clinical...Read more
China approves phase II trial of Akeso's cancer drug
Drug Discovery | News | 0 Comment | 08 Mar, 2022
Akeso, Inc., a biopharmaceutical company dedicated to the development of innovative antibody drugs, has announced that t...Read more
I-Mab receives FDA orphan drug designation for cancer drug
Drug Discovery | News | 0 Comment | 04 Mar, 2022
China based I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercializa...Read more
China-based startup InxMed raises $50 M in Series B Financing
Drug Discovery | News | 0 Comment | 04 Mar, 2022
InxMed Co., Ltd, a clinical-stage biotechnology startup based in China, has announced that it had completed $5...Read more
China's Adagene partners with French firm Sanofi for Immuno-Oncology
Drug Discovery | News | 0 Comment | 03 Mar, 2022
China's Adagene, a company transforming the discovery and development of antibody-based therapies, has announced a...Read more